As TSC1 or TSC2 mutations occur in cancers, we sought to determine if the TSC2 loss-of-function expression signature was present in human bladder tumors since this tumor type often sustains inactivating TSC1 or TSC2 mutations. Here, TSC1 is linked to neoplasm.